Germany Diabetes Devices Market - Growth, Trends, and Forecasts (2018 - 2023)

Germany Diabetes Devices Market - Growth, Trends, and Forecasts (2018 - 2023)

Purchase Report

The countries in the European region have high prevalence of diabetes. Russia and Germany accounts for close to 46% of diabetic population in the region in 2017. Modern obesogenic environments, with the combination of unhealthy diet and physical inactivity, have serious implications for type-2 diabetes. The type-2 diabetic population in most of the countries in the Europe accounts for about 90% of the diabetic population. In Europe, diabetes has become one of the most threatening disease, and is increasing in an alarming rate. Unfortunately, Germany rates high in this list.

Germany is one of the developed countries and advanced in terms of healthcare facilities. Technologies, such as continuous glucose monitoring and insulin infusion pump are getting adopted rapidly in Germany than the other developing countries. Moreover, the reimbursement policy and the pricing policy are highly regulated, which drive the market and increase the adoption rate of the diabetes patients to the newer and advanced technology.

In the European diabetes devices market, Germany accounts for the close to 28.4% of the total market value in 2017. By 2023, the diabetes device market in Germany is expected to grow, with a moderate CAGR of 4.0% during the forecast period. The roll-out of many new drugs, increasing international research collaborations in technology advancement, and increasing awareness about diabetes among the people are some of the market opportunities for the market players.

Germany’s diabetes devices market is broadly segmented based on the types into glucose monitoring devices segment and the management device segment. The glucose monitoring devices segment is further segmented into blood glucose meter, blood glucose testing strip, lancet, and continuous glucose monitoring device (CGM). Based on insulin delivery devices, the market is further segmented as syringes, pens, pumps, and injectors.

Key Players:

Abbott Diabetes Care, Roche, Johnson & Johnson, Arkray, Ascensia Diabetes Care, AgaMatrix, LifeScan, Sanofi, Dexcom, Medtronic, Ypsomed, Novo Nordisk, Eli lilly.

Key Developments:  

Jan 2018: Profil a Germany Company, conducting research on insulin pump. They perform clinical trials studies comparing the pump with the conventional insulin injection therapy using insulin syringes or an insulin pen.

Report Scope:



Base year for estimation


Review Period


Forecast Period

2018 – 2023

Market Representation

Revenue in USD billion and CAGR from 2018 – 2023

Regions covered


Report coverage

Revenue forecast, market share analysis, and market dynamics

Reasons to Purchase this Report:

  • To study current and future market outlook in the Indiamarkets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • Detailed analysis of the segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identifying the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet in excel

Report Customization and Benefits:

This report can be customized to meet the desired requirements. Please connect with our analyst, who will ensure that you get a report that suits your needs.



1. Introduction

            1.1 Scope of Study

            1.2 Market Definition

            1.3 Executive Summary

2. Research Methodology

            2.1 Study Deliverables

            2.2 Study Assumptions

            2.3 Research Phases

3. Market Insights

            3.1 Current Market Scenario

            3.2 Industry Attractiveness - Porter's Five Forces Analysis

                        3.2.1 Bargaining Power of the Suppliers

                        3.2.2 Bargaining Power of the Consumers

                        3.2.3 Threat of New Entrants

                        3.2.4 Threat of Substitute Products and Services

                        3.2.5 Competitive Rivalry within the Industry

4.  Market Dynamics

            4.1 Drivers

            4.2 Restraints

            4.3 Opportunities

5. Market Segmentation and Analysis

            5.1 Monitoring Device

                        5.1.1 Self Blood Glucose Monitoring

                           Glucometer Device

                                       Blood Glucose Meters

                                                   Blood Glucose Meters, Revenue(2012-2023)

                                                   Blood Glucose Meters, Volume(2012-2023)

                           Glucometer consumables

                                       Blood Glucose Test strips

                                                   Blood Glucose Test strips, Revenue(2012-2023)

                                                   Blood Glucose Test strips, Volume(2012-2023)


                                                   Lancets, Revenue(2012-2023)

                                                   Lancets, Volume(2012-2023)

                        5.1.2 Continous Blood Glucose Monitoring


                                       Durables, Revenue(2012-2023)

                                       Durables, Volume(2012-2023)


                                       Sensors, Revenue(2012-2023)

                                       Sensors, Volume(2012-2023)

            5.2 Management Device

                        5.2.1 Insulin Pump

                           Insulin Pump Device

                                       Insulin Pump Devices, Revenue(2012-2023)

                                       Insulin Pump Devices, Volume(2012-2023)

                           Insulin Pump Reservoir

                                       Insulin Pump Reservoirs, Revenue(2012-2023)

                                       Insulin Pump Reservoirs, Volume(2012-2023)

                           Infusion Set

                                       Infusion Sets, Revenue(2012-2023)

                                       Infusion Sets, Volume(2012-2023)

                        5.2.2 Syringes

                           Syringess, Revenue(2012-2023)

                           Syringess, Volume(2012-2023)

                        5.2.3 Cartridges

                           Cartridgesss, Revenue(2012-2023)

                           Cartridgesss, Volume(2012-2023)

                        5.2.4 Disposable Pens

                           Disposable Penss, Revenue(2012-2023)

                           Disposable Penss, Volume(2012-2023)

                        5.2.5 Jet Injectors

                           Jet Injectors , Revenue(2012-2023)

                           Jet Injectors , Volume(2012-2023)

6. Key Player Profiles

            6.1 Abbott Diabetes Care

            6.2 Roche

            6.3 Johnson & Johnson

            6.4 Arkray

            6.5 Ascensia Diabetes Care

            6.6 AgaMatrix, Inc.

            6.7 LifeScan

            6.8 Sanofi

            6.9 Dexcom

            6.10 Medtronic

            6.11 Novo Nordisk

            6.12 Becton Dickinson

            6.13 Eli Lilly

            6.14 Ypsomed Holding AG

* Each Company Profile include overview, Revenue, Product and services, Swot, Recent Activities and strategic Analysis.

Purchase Report

Our Clients Include View All

Looking to Customize Report?

Complete your payment details below

Shipping & Billing Information

Payment Information